In this podcast episode, Amy DeZern, MD, MHS, Daniel Pollyea, MD, MS, and Amer Zeidan, MBBS, discuss challenging cases in MDS, including

Treatment for MDS after ESA failure
Strategies for patients with intermediate- or high-risk MDS
Luspatercept therapy in MDS
MDS case challenges

Link to full program, including downloadable slidesets:
https://bit.ly/3tYwcYu

Presenters:
Amy E. DeZern, MD, MHS
Associate Professor
Oncology and Medicine
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Daniel Pollyea, MD, MS
Associate Professor of Medicine
Clinical Director of Leukemia Services
Division of Hematology
University of Colorado School of Medicine
Aurora, Colorado

Amer Zeidan, MBBS
Associate Professor, Internal Medicine
Hematology
Yale University
New Haven, Connecticut

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Cancer Conversations: 3 Case Challenges of Real Patients With Myelodysplastic Syndromes